Organon

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

Women’s health remains a big area of unmet medical need and since women make up half the population, the commercial opportunity is enormous, but investment in therapeutics for women – whether for fema

Chinese manufacturer Shanghai Henlius Biotech has notched up a further milestone after its HLX11 proposed biosimilar to Roche’s Perjeta (pertuzumab) was accepted for filing by the US Food and Drug Adm

Last week’s J.P. Morgan Healthcare Conference in San Francisco generated multiple headlines for the generics and biosimilars industry, with Generics Bulletin bringing you dedicated stories on the la